Divi's Lab Nosedives Nearly 20% On US FDA Alert

Shares of Divi's Laboratories plunged nearly 20 per cent on the Bombay Stock Exchange after the company said that US-FDA has issued an Import Alert 66-40 on the products manufactured at the company's

Subscribe to GoodReturns

Shares of Divi's Laboratories plunged nearly 20 per cent on the Bombay Stock Exchange after the company said that US-FDA has issued an Import Alert 66-40 on the products manufactured at the company's Unit-II at Visakhapatnam, Andhra Pradesh.

Divi's Lab Nosedives Nearly 20% On US FDA Alert
Weighed down by the development, shares of company declined as much as 19.69 per cent to hit intra-day low of Rs 635.00 apiece on the Bombay Stock Exchange.

In a similar fashion, stocks of company slipped 18.49 per cent to Rs 640.90 apiece on the National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 29,428.42, down 90.32 points or 0.31 per cent, at 11:55 hours.

Read more about: divis laboratories
Story first published: Tuesday, March 21, 2017, 12:50 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Find IFSC